Literature DB >> 19152133

Relationship between atrial fibrillation and blunted hyperemic myocardial blood flow in patients with hypertrophic cardiomyopathy.

Roberto Sciagrà1, Barbara Sotgia, Iacopo Olivotto, Franco Cecchi, Stefano Nistri, Paolo G Camici, Alberto Pupi.   

Abstract

BACKGROUND: Atrial fibrillation (AF) and coronary microvascular dysfunction (CMD) are common in hypertrophic cardiomyopathy (HCM), but whether they are associated is unclear. We assessed the relationship between AF and CMD in HCM. METHODS AND
RESULTS: Global hyperemic myocardial blood flow (hMBF) was measured in 95 HCM patients (16 with, 79 without paroxysmal or chronic AF) by N-13 ammonia positron emission tomography (PET) after dipyridamole infusion. AF patients were older (50.5 +/- 13.4 vs. 38.7 +/- 14.9 years, P < .0005), had larger left atrial diameter (49.8 +/- 7.4 vs 38.6 +/- 5.7 mm, P < .00001), and left ventricular end-systolic diameter (30.4 +/- 6.7 vs 25.5 +/- 5.3 mm, P < .005) compared with those in stable sinus rhythm. In patients with AF, hMBF was significantly lower (1.23 +/- 0.44 vs 1.87 +/- 0.90 mL/min/g, P < 0.0001). In multivariate logistic regression analysis, hMBF, left atrial diameter, and age were independently associated with AF (P < .05 for all).
CONCLUSIONS: HCM patients with paroxysmal or chronic AF have lower hMBF than those in stable sinus rhythm. The association between CMD and AF is independent of other known predictors of AF, suggesting a causal link between these two features.

Entities:  

Mesh:

Year:  2009        PMID: 19152133     DOI: 10.1007/s12350-008-9005-5

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  20 in total

1.  ACC/AHA Guidelines for the Clinical Application of Echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography). Developed in collaboration with the American Society of Echocardiography.

Authors:  M D Cheitlin; J S Alpert; W F Armstrong; G P Aurigemma; G A Beller; F Z Bierman; T W Davidson; J L Davis; P S Douglas; L D Gillam
Journal:  Circulation       Date:  1997-03-18       Impact factor: 29.690

2.  Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy.

Authors:  I Olivotto; F Cecchi; S A Casey; A Dolara; J H Traverse; B J Maron
Journal:  Circulation       Date:  2001-11-20       Impact factor: 29.690

3.  Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging.

Authors:  G D Hutchins; M Schwaiger; K C Rosenspire; J Krivokapich; H Schelbert; D E Kuhl
Journal:  J Am Coll Cardiol       Date:  1990-04       Impact factor: 24.094

Review 4.  Hypertrophic cardiomyopathy: a systematic review.

Authors:  Barry J Maron
Journal:  JAMA       Date:  2002-03-13       Impact factor: 56.272

5.  Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy).

Authors:  Stefano Nistri; Iacopo Olivotto; Sandro Betocchi; Maria Angela Losi; Grazia Valsecchi; Bruno Pinamonti; Maria Rosa Conte; Franco Casazza; Maurizio Galderisi; Barry J Maron; Franco Cecchi
Journal:  Am J Cardiol       Date:  2006-08-14       Impact factor: 2.778

6.  Simultaneous in vitro and in vivo validation of nitrogen-13-ammonia for the assessment of regional myocardial blood flow.

Authors:  C R Bellina; O Parodi; P Camici; P A Salvadori; L Taddei; L Fusani; R Guzzardi; G A Klassen; A L L'Abbate; L Donato
Journal:  J Nucl Med       Date:  1990-08       Impact factor: 10.057

7.  Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease.

Authors:  A M Varnava; P M Elliott; S Sharma; W J McKenna; M J Davies
Journal:  Heart       Date:  2000-11       Impact factor: 5.994

8.  Increased risk of sudden and non-sudden cardiovascular death in patients with atrial fibrillation/flutter following acute myocardial infarction.

Authors:  Ole Dyg Pedersen; Steen Z Abildstrøm; Michael M Ottesen; Christian Rask-Madsen; Henning Bagger; Lars Køber; Christian Torp-Pedersen
Journal:  Eur Heart J       Date:  2005-11-02       Impact factor: 29.983

9.  Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy.

Authors:  Franco Cecchi; Iacopo Olivotto; Roberto Gistri; Roberto Lorenzoni; Giampaolo Chiriatti; Paolo G Camici
Journal:  N Engl J Med       Date:  2003-09-11       Impact factor: 91.245

10.  Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy.

Authors:  Iacopo Olivotto; Franco Cecchi; Roberto Gistri; Roberto Lorenzoni; Giampaolo Chiriatti; Francesca Girolami; Francesca Torricelli; Paolo G Camici
Journal:  J Am Coll Cardiol       Date:  2006-03-07       Impact factor: 24.094

View more
  6 in total

1.  Role of quantitative myocardial positron emission tomography for risk stratification in patients with hypertrophic cardiomyopathy: a 2016 reappraisal.

Authors:  Helga Castagnoli; Cecilia Ferrantini; Raffaele Coppini; Alessandro Passeri; Katia Baldini; Valentina Berti; Franco Cecchi; Iacopo Olivotto; Roberto Sciagrà
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-08-16       Impact factor: 9.236

Review 2.  Microvascular dysfunction, myocardial ischemia, and progression to heart failure in patients with hypertrophic cardiomyopathy.

Authors:  Franco Cecchi; Aurelio Sgalambro; Massimo Baldi; Barbara Sotgia; Davide Antoniucci; Paolo G Camici; Roberto Sciagrà; Iacopo Olivotto
Journal:  J Cardiovasc Transl Res       Date:  2009-11-03       Impact factor: 4.132

3.  Is there a role for cardiac positron emission tomography in hypertrophic cardiomyopathy?

Authors:  Paco E Bravo
Journal:  J Nucl Cardiol       Date:  2018-05-14       Impact factor: 5.952

4.  The Impact of Ischemia Assessed by Magnetic Resonance on Functional, Arrhythmic, and Imaging Features of Hypertrophic Cardiomyopathy.

Authors:  Sílvia Aguiar Rosa; Boban Thomas; António Fiarresga; Ana Luísa Papoila; Marta Alves; Ricardo Pereira; Gonçalo Branco; Inês Cruz; Pedro Rio; Luis Baquero; Rui Cruz Ferreira; Miguel Mota Carmo; Luís Rocha Lopes
Journal:  Front Cardiovasc Med       Date:  2021-12-17

5.  Association of Retinal Microvascular Signs with Incident Atrial Fibrillation: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Gen-Min Lin; Laura A Colangelo; Barbara E K Klein; Mary Frances Cotch; Tien Y Wong; Carol Y Cheung; Susan R Heckbert; Alvaro Alonso; Younghoon Kwon; Richard A Kronmal; Donald M Lloyd-Jones; Kiang Liu
Journal:  Ophthalmol Retina       Date:  2020-06-19

Review 6.  Quantitative cardiac positron emission tomography: the time is coming!

Authors:  Roberto Sciagrà
Journal:  Scientifica (Cairo)       Date:  2012-08-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.